Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0681
+0.0021 (3.18%)
Oct 28, 2025, 9:30 AM EDT
PVCT Market Cap
PVCT has a market cap or net worth of $29.75 million as of October 28, 2025. Its market cap has decreased by -35.35% in one year.
Market Cap
29.75M
Enterprise Value
31.89M
Revenue
460.19K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 29.75M, an increase of 688,240.63%. That is a compound annual growth rate of 45.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 30.85M | -38.88% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | 23.43M | -5.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |